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COVID-19-related disruptions of people and goods’ circulation can affect drug markets,
especially for new psychoactive substances (NPSs). Drug shortages could cause a
change in available NPS, with the introduction of new, unknown, substances. The aims of
the current research were to use a web crawler, NPSfinder®, to identify and categorize
emerging NPS discussed on a range of drug enthusiasts/psychonauts’ websites/fora
at the time of the pandemic; social media for these identified NPS were screened as
well. The NPSfinder® was used here to automatically scan 24/7 a list of psychonaut
websites and NPS online resources. The NPSs identified in the time frame between
January and August 2020 were searched in both the European Monitoring Center
for Drugs and Drug Addictions (EMCDDA)/United Nations Office on Drugs and Crime
(UNODC) databases and on social media (Facebook, Twitter, Instagram, Pinterest,
and YouTube) as well, with a content qualitative analysis having been carried out on
reddit.com. Of a total of 229 NPSs being discussed at the time of the pandemic,
some 18 NPSs were identified for the first time by the NPSfinder®. These included
six cathinones, six opioids, two synthetic cannabinoid receptor agonists (SCRAs), two
phenylcyclohexylpiperidine (PCP)-like molecules, and two psychedelics. Of these NPSs,
10 were found to be previously unreported to either the UNODC or the EMCDDA. Of
these 18 NPSs, opioids and cathinones were the most discussed on social media/reddit,
with the highest number of threads associated. Current findings may support the use
of both automated web crawlers and social listening approaches to identify emerging
NPSs; the pandemic-related imposed restrictions may somehow influence the demand
for specific NPS classes.
Keywords: COVID-19, new psychoactive substances, NPS, NPSfinder®, web crawler, drug misuse
INTRODUCTION
The COVID-19 pandemic has been considered as the worst global crisis after the global financial
crash of 2007–2008 (1–3). This was caused by massive disruptions in goods’ markets and
restrictions imposed on individuals’ movements (home confinement) followed by the total blocking
of air and land travel (January–June 2020) (4). These primary measures generated a substantial
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economic burden at international, national, and community
levels, forcing the general population to face psychological
difficulties and behavioral changes (5–8). Of particular concern
are people who use drugs (PWUDs) (9, 10). It is well-known how
acute or chronic stress can have a pivotal role in the inception of
substance abuse and in the worsening of substance use disorders
(6, 11).
COVID-19 measures affected the illegal drug markets as
well, from production, trafficking, and marketing through to
availability and demand. These aspects have been affected in
different ways across different countries, with the exception of
the retail markets, which have undergone a more homogeneous
change. Drug shortages, stockpiling, increase in prices, and
reduction in purity were reported across the world (12).
This was true especially for the more established drugs like
cocaine and heroin, which are produced in specific areas of
the world (e.g., South America and Afghanistan) and which
rely on open legal commercial routes to be moved around
(13). New psychoactive substances (NPSs) (14) encountered
a different fate. A diversification of the market was expected
between January and June 2020 (12, 15) due to shortages of
treatment and classic opiate and opioid drugs (16) pushing
users to synthetic available alternatives; lack of precursors
for synthetic drugs diverting productions toward new NPS
analogs; the economic problems and anxiety caused by the
pandemic forcing PWUDs to use cheaper and seek more
potent substances; and increased drug e-commerce that followed
the restrictions of individual movements (12) facilitating the
distribution of NPSs. The expected trend of PWUDs switching to
and/or increasingly accessing counterfeit/unknown drugs online
represents a serious health threat that should be investigated
and monitored.
Monitoring of social media platforms could aid in identifying
emerging NPSs during the COVID-19 pandemic. In recent years,
social media increased their popularity as interacting platforms,
in which users and suppliers of drugs can communicate
freely, e.g., about price, purity, pharmacological/toxicological
effects, way of administration, dosages of substances, with
particular regard to newly introduced/synthesized ones.
The analysis of available online information [qualitative
analysis (17)] can be an effective tool to understand and
identify consumers’ needs and decisions and markets supplies
and demands’ balance. Overall, “social media listening”
has been proven to be an effective tool for public health
concerns (18).
The aims of the current research were to use a web crawler,
NPSfinder R©, to identify and categorize emerging NPSs
discussed on a range of drug enthusiasts’ websites/fora
at the time of the COVID-19 pandemic; compare the
NPSfinder R© results with related listings from the European
Monitoring Center for Drugs and Drug Addictions
(EMCDDA) and United Nations Office on Drugs and
Crime (UNODC) databases (19, 20); screen social media
(Facebook, Twitter, Instagram, Pinterest, YouTube) for
identified NPSs; and conduct a qualitative analysis (reddit)




As better specified in Arillotta et al. (21), NPSfinder R© is a
crawling/navigating, password-protected, proprietary software,
which allows registered researchers only to screen and classify the
molecules being identified. Indeed, NPSfinder R© automatically
scans on a 24/7 basis a range of website addresses/uniform
resource locator (URLs) for new/novel/emerging NPSs [see also
(22, 23)]. When a novel substance is found, this is added to
the growing NPSfinder R© database. NPSfinder R© was used here
to facilitate identification of the range of NPSs discussed online
from January to August 2020. Although one could argue that in
January and February the European Union and the United States
did not have any restrictions in place, the restrictions were at
that time clearly in place in China (24), a country that has been
suggested as being involved in the production/supplying of both
synthetic drugs (NPSs) and synthetic drug precursors (4).
The scanned URLs were representative of online psychonauts’
websites/fora and other NPS online resources (see Appendix 1).
NPSfinder R© was designed by Damicom, an information
technology enterprise based in Rome (Italy), to extract a
range of information regarding NPSs including chemical and
street names, chemical formulas, three-dimensional images,
and anecdotally reported clinical/psychoactive effects. The data
extracted were automatically stored in an online, restricted-
access/password-controlled database. The predominant language
was English, but other languages were also considered: Spanish,
German, Russian, Italian, Dutch, French, Swedish, and Turkish.
From all the data extracted by the web crawler, the range of
unique NPSs being identified was assigned to their NPS class,
according to the indications taken from a range of literature
papers (25–27).
Comparison Between NPSfinder®,
EMCDDA, and UNODC Databases
To assess the possible novelty of NPSfinder R© findings, the NPS
molecules here identified for the first time by web crawler
at the time of the COVID-19 pandemic were compared with
entries available from both the EMCDDA’s European Database
on New Drugs (19) and UNODC Early Warning Advisory on
NPS database (20). JMC, a registered user with authorized access
to these databases, prepared the listing for the comparison. The
comparison was conducted using the International Chemical
Identifier Key (InChIKey) (28, 29).
Social Networks’ Analysis
In order to better understand the online overall scenario of
those NPSs first identified by the web crawler at the time of the
COVID-19 pandemic, a range of social networks (e.g., Facebook;
YouTube; Twitter; Instagram; Pinterest, reddit) were investigated
as well. An observational qualitative analysis, in the time frame
September–October 2020, was here performed, and these social
networks were chosen because of their popularity, e.g., number of
users. A similar approach has already been used by this research
group in other studies (18, 21). A content qualitative analysis
was conducted on reddit (30), which is a web-based platform
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that organize topics into fora known as subreddits, where each
discussion is considered a thread. Reddit is well-known for its
ability in engaging users and reporting good-quality information
on a great variety of topics (30–33); these characteristics make
this platform as a very popular source for social listening studies
(34–37). Reddit fora entries are anonymous and voluntary.
The subreddit called “r/Researchchemical” (38) was initially
analyzed for the purpose of this article. “r/Researchchemical”
is defined as the subreddit for the discussion of synthetic
psychoactive research chemicals, also known as NPSs. When
the threads were analyzed, the group had 94,000 members.
The terms used for the search were the here newly identified
substances, their chemical names, and street names. During the
search, other subreddits were deemed relevant to the current
study and were hence included in the qualitative analysis, e.g.,
“r/opiods.RCS,” “r/stims,” “r/noids,” and “r/dissociatives” (39–
42). Two independent researchers, with different backgrounds
in qualitative research, analyzed independently all the relevant
threads. The dataset analysis was conducted manually without
the use of any software. The subreddits were screened after the
analysis of the data provided by NPSfinder R© was concluded
and the new molecules identified; to allow optimal collection of
qualitative data, no time restrictions were used for the reddit
qualitative analysis.
RESULTS
The NPSfinder R© web crawler has been active since November
2017 and to date reported a total of 4,335 NPSs found on
the surface web. For this study, data were collected between
January and August 2020. During this time frame, the web
crawler identified a total of 229 substances (Appendix 2) as
being discussed and commented by psychonauts; out of these,
and after careful evaluation, 18 were recognized as previously
unidentified and new to the NPSfinder R©. Proper categorization
and descriptive statistics were produced for these 229 molecules
(Table 1); most popular NPS categories being commented
on included synthetic cannabinoid receptor agonists (SCRAs),
synthetic opioids, and cathinones.
The 18 newly identified molecules, categorized in line with
both Abdulrahim and Bowden-Jones (25) and Schifano et al. (26),
included six cathinones, six opioids, two cannabimimetics, two
phenylcyclohexylpiperidine-like substances, one hallucinogen,
and one tryptamine. In order to understand if these molecules
were not only new but unique to NPSfinder R©, a comparison with
the UNODC and EMCDDA databases was made. As a result,
10 NPSs were identified as previously unknown/unreported
(Table 2). For three of the six new cathinones (Table 2), no
information on chemical structure or composition was available,
and the molecules appeared here to be totally unknown.
All the 18 molecules identified were identified across a
variety of vendor sites (56–59). Only few hits were obtained by
the analysis of Facebook, YouTube, Instagram, and Pinterest,
whereas on Twitter 7 of these 18 molecules were identified and
commented on. Of these, four were identified on the seller’s
profiles only (MFPVP, MD-PV8, 5F-NPB-22, and nortilidine):
TABLE 1 | Descriptive statistics of the 229 NPS identified from January to August
2020.















The molecules identified were divided by NPS class, and the percentage per
class calculated.
two in posts/discussions (A-PCYP, 4F-MDMB-BICA), and
only one was mentioned within a trip report (1F-LSD).
Three molecules (5F-NBP-22, MFPVP, Etazene) were found on
Facebook, Pinterest, and Instagram on the sellers’ profiles, and
only one (3-Cl-PCP) was found on YouTube (e.g., within a
trip report).
Conversely, the outcome of the qualitative analysis conducted
on the subreddits for these 18 substances provided here more
comprehensive results. Across all subreddits, threads were found
for all but two of the 18 molecules (i.e., HEP and 5F-NPB22). The
subreddit called “r/Researchchemical” included most threads for
all the NPS classes, although opioids seemed to be discussedmore
often on their dedicated subreddit (“r/opiods.RCS”). Overall, the
threads/posts relating to these NPSs were entered by redditors
starting in a period that range from 2018 to beginning of
2020; whenever possible, the first data post was here identified
and analyzed. Overall, older threads were found to be less
informative (e.g., in terms of effects, toxicity, dosage, and ways of
administrations) than most recent ones. The threads focusing on
trips, effects, and routes of administration seemed to attract the
most interest, whereas most popular NPSs included opioids and
cathinones, followed by PCP-like molecules and psychedelics.
The total number of threads focusing on opioids was 188, of
which 84 were on brorphine and 85 on etazene. The oldest thread
related to diphenpipenol and was dated August 2019, whereas
most recent threads focused on both brorphine and etazene.
Etazene presented with the highest number of posts associated
with a thread, followed by brorphine and fluonitazene. Among
the opioid threads, the highest number of posts was identified
as those discussing/comparing several synthetic opioids, with
particular attention to tolerance and dosages (Table 3).
The total number of threads identified for cathinones was
101, of which 70 threads were for A-PCYP only. The oldest
thread was dated January 2019 for EBK-EBDP, whereas the most
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TABLE 2 | List of NPS identified for the first time by NPSfinder® from January to August 2020.









It is the 3-methyl derivative of 4F-alpha-PVP. Cathinones,
which are structurally like 4F-α-PVP, cross the brain-blood
barrier effectively (43). No information has been retrieved on
its mechanism of action, but it is likely to affect the
monoaminergic system, particularly the dopamine
transport, as the 4F-PVP. It is a stimulant.
N 23/07/2020






MDPEP is a stimulant of the Cathinone class, which has
been reported as a novel designer drug (44). MD-PEP is the
methylendioxy derivative of α-PEP and the higher homolog
of α-pyrrolidinohexiophenone (α-PHP), having an extra
carbon on the alkyl side chain. No in vitro studies are
available to assess the activity on the brain but based on
previous work the longer alkyl chain may increase its
potency (45).
N 06/05/2020
EBK-EBDP Cathinones N.a. EBK-EBDP is probably a mixture of EBK, a new synthetic
derivative of βk-EBDP/ephylone, and ephylone itself. On the
website where the molecule was first identified by the
NPSfinder®, C20H27FN2O3 was the molecular formula
reported. The description was then changed to EBK alone.
Other chemical formulas are available online for the same
compound. It is sold as a potential strong stimulant with
powerful psychotic effects.
Y 06/05/2020
HEP Cathinones N.a. HEP belongs to cathinone and amphetamine chemical





A-PCYP is a stimulant drug of the cathinone class that has
been sold online as a designer drug. In a series of
α-substituted pyrrolidinyl cathinone derivatives developed in
2015, the α-cyclopentyl derivative was found to have
around the same potency in vitro as an inhibitor of the
dopamine transporter as the α-propyl derivative a-PVP,
while the α-cyclohexyl derivative α-PCYP was around twice
as strong (46).
Y 06/03/2020




4F-MDMB-BICA is a synthetic cannabinoid structurally
similar to 4F-MDMB-BINACA and 5F-MDMB-PICA.
5F-MDMB-PICA is explicitly a Schedule I substance in the








5-F-NPB-22 is an analog of NPB-22 that differs by adding a







Etazene was notified as an NPS on 1 June 2020 by Poland
(49). The substance belongs to the 2-benzylbenzimidazole
group of synthetic opioid analgesics; It is less potent than







Metodesnitazene is a 2-benzylbenzimidazole. It is
structurally related to etonitazene (Schedule I of the 1961
United Nations Single Convention on Narcotic Drugs), with
the presence of an ethoxy group instead of the methoxy
and the absence of the nitro group at the 5 position. The
analgesic activity of the 2-benzylbenzimidazole appears to
be related to the substitution at the benzyl moiety with para
substitution showing higher activity (52).
N 23/07/2020
(Continued)
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TABLE 2 | Continued










It is a novel opioid of the 5-nitro-2-benzylbenzimidazole
family that shares the same structure as Clonitazene but








Brorphine is a piperidine benzimidazolone
(3-piperidin-4-yl-1H-benzimidazol-2-one). It shares
structural similarities with the internationally controlled
narcotic analgesic bezitramide and with the benzimidazole
opioids isotonitazene and etazene. However, the latter






Diphenpipenol was invented in the 1970s by Dainippon
Pharmaceutical Co (53). It is an opioid analgesic, derivative
of 1-substituted-4-(1,2-diphenylethyl)piperazines. It is
related to MT-45 and AD-1211, being the most potent
compound in the series. The (S) isomer has 105 times the
potency of morphine in animal studies (54). This makes it a
similar strength to fentanyl and consequently diphenpipenol
can be considered a threat to life expected to cause






Nortilidine is the major demethylated active metabolite of
tilidine. The racemate has opioid analgesic effects roughly
equivalent in potency to that of morphine (55). The drug




3-Chlorophencyclidine (3-CL-PCP) is a dissociative
anesthetic drug with hallucinogenic and sedative effects
that has been sold as a research chemical. It has
comparable potency to phencyclidine but slightly different
effects. This is due to its altered binding profile at various
targets, particularly being somewhat more potent as an
NMDA antagonist while having around the same potency as




3-F-PCP is a dissociative hallucinogen of the aryl
cyclohexylamine class related to phencyclidine (PCP) which
has been sold online as a designer drug. It is the fluorinated
analog of the 3-MeO-PCP, substance listed in UK as Class
B of the Misuse of Drugs Act (1971). No in vitro studies
have been found for this compound but due to the similarity
with 3-MeO-PCP it should act acts mainly as an NMDA
receptor antagonist interacting with the sigma σ1 receptor









1-formyl-lysergic acid diethylamide is a chemical analog of
ALD-52, which is a formyl group on position 1 instead of an





5-chloro-N,N-dimethyltryptamine is a novel, naturally
occurring tryptamine found in certain species of deep
marine sea sponges, including Smenospongia aurea and
Smenospongia echina. It is closely related to 5-bromo-DMT.
It was assayed for the in vitro serotonin binding receptors. It
showed high nanomolar affinity to several serotonin
receptors subtype. The highest affinity was observed
N 03/08/2020
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TABLE 3 | Most popular reddit threads for each of the NPS classes identified by the NPSfinder® between January and August 2020.
NPS class Total threads Most discussed threads No. of posts
Opioids 118 “Etazene Taper from Methadone Q’s” 70
“Etazene extinct?” 55
“Brorphine and Metodesnitazene.” 47
“Fluonitazene” 35
“A few Interesting Opioid Molecules I came up with and the respective Swiss Target Prediction” 63
“which rc opioid?” 38
Cathinones 101 “Raning about A-PCyP” 68
“a-PCyP: just say no to snorting it” 33
“MFPVP/mf-pvp/3m-4f-pvp REPORT” 30
“MDPEP (as known as MD-PV8) turns out do be a good replacement cathinone in terms of
duration & effects similar to MDPV or MDPHP”
22
PCP-like 21 “3-F-PCP and World Domination—Phase Two Underway” 91
“New Stuff’s comin’-−3-F-PCP,” 81
“3-chloro-pcp! it’s really nice!” 50
“My Initial Impressions of 3-CL-PCP” 32
Psychedelics 10 “1F-LSD 100 mcg (A New Lysergamide)—First Trip Report” 129
“1F-LSD (150 µg sublingual): Novel lysergamide report” 80
Synthetic
cannabinoids
5 “5-Bromo-DMT and 5-Chloro-DMT coming soon I think” 34
“Warning 4F-MDMB-BICA caused 11 deaths in Hungary” 120
“4f mdmb bica super potent” 16
The threads can be found in the following subreddits: “r/Researchchemical,” “r/opiods.RCS,” “r/stims,” “r/noids,” and “r/dissociatives”.
recent focused on MFPVP. Most posts were associated with
A-PCYP, commenting on trip reports and effects and routes of
administration (Table 3). For the two PCP-like molecules, a total
of 21 threads were identified with discussions that started in
March 2020. The highest number of posts related to 3-F-PCP
(Table 3). Some 10 threads were associated with the psychedelics
1F-LSD and 5-Cl-DMT; related discussions started in January
2019 for 1F-LSD (Table 3). Finally, only five threads were here
associated with SCRAs; related discussions started in August
2020, and the latest one in October 2020.
A selection of anecdotal data from the related subreddits
referring to the 18 NPSs’ availability, desired effects, side effects,
routes of administration, onset of action, etc., is reported in
Table 4.
DISCUSSION
The present article provided a unique insight into the world of
the NPSs being discussed online at the time of the COVID-
19 pandemic. The results presented here for the activity of the
NPSfinder R© web crawler showed the importance of the web as an
essential source to understand and assess the NPS phenomenon
(60). Indeed, previous research from our group (21–23, 61)
showed how the overall numbers of synthetic cathinones,
opioids, benzodiazepines, and SCRAs identified online since the
launch of NPSfinder R© (November 2017) were higher than those
reported to, and listed by, both the EMCDDA and the UNODC.
Some 10/18 of the molecules here identified and commented
online at the time of the pandemic were unknown/unreported
NPSs (19), and this may highlight the potential of automated web
crawlers to accurately describe the evolving drug scenarios.
The 18 molecules identified were distributed across the
different NPS classes, roughly in line with international data
(4, 62, 63). Conversely, in contrast with recent annual reports
indicating an increase in designer/ “exotic” benzodiazepines’
number, type, and availability (64, 65), these molecules did not
feature here between those first identified by NPSfinder R© at the
time of the COVID-19 pandemic. One could, however, argue that
with the COVID-related disruption of medical/health services
(66–68), patients, as it has happened in the United Kingdom,
may well have managed to get access to large prescription
batches of prescription drugs, hence the decreased need to access
the web for designer alternatives. Indeed, an increase in the
consumption of prescription benzodiazepines has recently been
reported (69). Of the 229 NPSs being discussed online at the time
of the pandemic, however, synthetic opioids were featured just
after SCRAs and were here one-third (e.g., 6/18) of those first
identified by the web crawler at the time of the pandemic (49, 65).
While the data obtained from Twitter, YouTube, Facebook,
and other social media were few and could not be used here as a
solid base for data interpretation, the parallel qualitative analysis
conducted on subreddits seemed to have well-supported the web
crawler findings. A massive interest toward synthetic opioids was
confirmed by the analysis of reddit entries, and this may have
paralleled the shortage of heroin (4, 16, 70–72).
The development of new synthetic opioids could worsen the
already worrisome worldwide opioid crisis (73–75). NPS opioids
are very powerful analgesics, characterized by severe adverse
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TABLE 4 | Information gathered from the qualitative analysis of reddit.com for the 18 molecules identified by NPSfinder®.
NPS Description Reddit threads
time frame
Opioids





“Looks like a bastard child of the active metabolite of bezitramide, and benzylfentanyl. Bezitramide was pulled off the
market due to overdoses. This one makes me nervous, too close to fentanyl to be safe”
“It appears the therapeutic index is quite low, from anecdotal reports. Which means that the overdose level is not very much
higher than the level needed to get high. I’ve also been told the high isn’t great and is not very euphoric compared to many
other opiates. I would stay far away from this stuff, and if you must use RC opioids, stick with the tried and true and
relatively safe O-desmethyltramadol.”




“It was total waste of money, completely inactive”
“Diphenpipenol review (…) It seems to be basically inactive. I have tried nasal vaping and iv use to no avail. Vaping doesn’t
work at all, burns product and smoke is extremely harsh on lungs. Burns a lot intranasally as well. Disappointed...”
Etazene Recently sold as designer drug and identified in June 2020. It is classified as novel opioid/research chemical opioid. It is a




“it is a very strong opioid. It differs slightly in action from classic opioids. It is a molecular speedball. If you take little, you feel
everything at once: euphoria, speed and relaxation. If you take more, euphoria is growing, but the opiate action profile is
getting stronger, until you finally fall into opioid drowsiness. Compared to isotonitazene and fentanyl, it was hardly seen to
cause respiratory depression.”
“If you don’t have an opioid tolerance and aren’t an experienced opioid user, this is not one you would want to purchase.
The reason it is dosed in nasal sprays is for volumetric dosing: basically you can be sure that each press of the nasal spray
is a certain amount, and it can be in micrograms. The difference between fine and overdosed/dead is under 10mg, which
you can’t even eyeball.”
Fluonitazene Very scares information May–September
2020
“Some Chinese vendor spat out a new nitazene. Fluonitazene should be stronger than clonitazene, about 20–40x
morphine. No idea if it’s legit” (39).
“I went on a 23 h binge—the legs on this thing is pretty good, but it’s also pretty sedating and not particularly euphoric. All in
all, I had a good time, but I ran out just before the 24 h mark. I felt really sad afterwards, and depression-slept for 10 h
straight, but after waking up this morning, I was glad that I threw most it out”
Metodesnitazene Recently sold as designer drug. It is classified as novel opioid/research chemical opioid. Even though there are a few trip
reports, it is a psychonaut substance of interest
January–May
2020
“meto-des-nitazene: Has a dosage like morphine. There are more interesting substances in this group. I do not recommend
buying” (42)
“It wasn’t until today, taking a 200 mg!! ……. that I felt anything………a minor codeine-like high right now. It started with
minor warmth in the head, not the typical opioid warmth we know and love but like I had been out in the sun for 10min.
From there it only progressed a little bit, giving me a very minor and not strong high. In conclusion, this drug is absolutely
not worth buying or looking into.”
Nortilidine Recently sold as a designer drug, it is a tilidine active metabolite with potential attractive effects for psychonauts. April 2018–July
2020
“It’s actually as strong as Morphine so it would be a worthwhile RC (…) I thought tilidine was a German speaking countries
only thing. It’s also marketed in Belgium Bulgaria and South Africa.”
Cathinones
3M-4F-αPVP Better known and mostly discussed on forums as “MFPVP” and widely traceable on the surface web (forums and sellers). May-September
2020
“R new flakka replacement….PURE PARANOIA on the comedown, its just awful without benzos, with them, its similar to a
good amphetamine experience or Molly-like experience”
“MFPVP/4F-3M-PVP is worth a try It’s actually surprisingly good, though pretty mild” (40)
“I noticed it is the only chem that vaping as an r.o.a doesn’t just trigger a weird head pressure and make me annoyed! I
didn’t try oral, never really do for anything, although not that I say that I am wondering why! It is a very short lasting rush,
even when IV’d (which is not really a good idea, especially if it’d new, but probably in general, but...self-destruction is human
nature I guess. I find insuffliation to be the best happy medium, vaping does seem to add side effects to almost every chem
(Hexen especially), but is likely specific to the individual as most effects appear dependent upon. Njot quite sure of dosage”
(Continued)
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TABLE 4 | Continued
NPS Description Reddit threads
time frame
4H-CMC Unknown compound June 2019
“Any experience with/knowledge of 4H-CMC?........ the only information they’re giving is that ‘it’s not 4-CMC.’ Request for
an IUPAC was not met.”
A-PCYP A very well-known, discussed and apparently appreciated cathinone. Info are available on various websites (e.g., Isomer




EBK-EBDP Unknown compound June 2019
“A blend of two relatively novel compounds needs purification. EBK (BK-EBDP analo) + Eutylone blend. Any ideas how to
do this?”
HEP No information on the web retrieved. N.a.
MD-PEP/MD-
PV8
Substituted cathinone traceable in some surface web vendor website. Apparently mostly unknown to the psychonauts.
According to some users, probably it is “MD-PV8” or a “MD-PHP analog” and it is shipped from China.
May 2019–April
2020
“MDPEP waste. MD PV8 cytotoxic almost 0 euphoria don’t try!)”
“It’s less potent, less euphoric and more dangerous than most other pyros. There was a guy that died from consuming




Described on some vendor websites. Sold as synthetic cannabinoid. User feedback not available on surface web. August–October
2020
5F-NPB-22 Described on some vendor websites. Sold as synthetic cannabinoid. User feedback not available on surface web. N.a.
PCP-like
3-CL-PCP Psychonauts seems to be interested in it. Few trip reports, being a new chemical. Widely traceable on the surface web on
vendor websites and some social media.
July–October
2020
“3-chloro-pcp! it’s really nice! So I tested 3-cl-pcp and it is similar to 3-meo-pcp with the hypomania and stimulation, but
also has a really comfy calm euphoria similar I believe if Im remembering correctly to ketamine. Lasts like 6 h with stimulation
for longer. but the stimulation is nice this time imo. 25mg is a very mild dose. 60mg was really fun! IT IS WAAAAY BETTER
THAN 3-FLUORO-PCP!”
3-F-PCP Various trip reports so far. PCP related substance, it has intrigued psychonauts since its introduction on the market. March–October
2020
“3 fluoro pcp is amazing. Got a sample of this last week with another order from china. And wow (…) It is one of the
cleanest, clearest, smoothest euphoria from any disso I have tried (and I’ve tried em all basically) Its stimulating yet relaxed.
Chill yet energizing. Not confusing in the least. Highly recommend trying this chemical whenever you can get your hands on
it. ROA was IV in dosages of 5–15 mg”
“30–40mg orally is where it becomes enjoyable (…) Ummm like if they wanted to make a tame version of pcp for hospital
anesthesia without totally tripping people out at the same time (…) Lasts about 2–3 h, but leaves you with a really long
lasting stimulation which can be either bad or good depending on the situation.”
Psychedelics





“It had a distinct visual character—while for me many other lysergamides create aforementioned discrete and distinct
contained visuals following animal forms and resembling various kinds of indigenous American art, 1F-LSD had a character
of more organic, free flowing visuals, with less color. The headspace was subtle and euphoric, given to earnest but pleasant
and merciful introspection, with a lot of holistic reflection on contentedness and the passage of time.”
5-CHLORO-
DMT
Not relevant info yet. February–October
2020
“There are a couple of vendors which sell these two tryptamines now, but there hasn‘t been any trip report about
5-Chloro-DMT released yet and there are only two reports about 5-Bromo-DMT”
The subreddits analyzed were “r/Researchchemical,” “r/opiods.RCS,” “r/stims,” “r/noids,” and “r/dissociatives”. (Note: Current anecdotal data refer to a range of redditors’ entries which
may be contribute to illustrate the level of the debate relating to the index NPS; no editing has been carried out).
effects such as abuse liability and respiratory depression (21).
Although none of the opioids first identified by NPSfinder R© at
the time of the pandemic was a structural analog of fentanyl
(76, 77), all potentially present with a similar threat to public
health (63) and are reported to be far more potent than
morphine (50, 54, 55). New synthetic opioids were derivatives of
different chemical families, such as 2-benzylbenzimidazole and
1-substituted-4-(1,2-diphenylethyl)piperazines. Diphenpipenol,
for example, presents with a similar strength to fentanyl, although
was anecdotally reported here as “inactive” and “a total waste of
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money.” It is possible that, although advertised as diphenpipenol,
the actual compound made available for purchase was one of its
structural isomers with a much weaker opioid activity (78). The
recent emergence of this group of opioids may suggest a step back
from fentanyl, arguably as a result of controlmeasures introduced
in the United States and China in 2019 (51).
The synthetic cathinones’ group was followed here in terms of
popularity on reddit. Differently from the synthetic opioids, this
result is slightly unexpected. In line with the increase reported in
the number of newly identified cathinones for 2019 (63), three of
the six cathinones identified as first discussed at the time of the
pandemic were previously unknown. Furthermore, we recorded
here an intense increased vendors’ activity to possibly counteract,
with cathinones, the threatened/expected shortage of cocaine
(13). However, the possible presence on the market of these
new compounds is a reason of concern, because of their well-
known severe side effects (e.g., paranoia, cognitive impairment,
hallucinations, violence, and suicidal thoughts) (79, 80) that
could worsen existing depression and trigger low mood induced
by COVID-19 (6).
Psychedelic and PCP-like molecules, despite being lower in
number compared to the other chemical classes identified, were
also discussed at the time of the pandemic. One could argue
that these categories of drugs, indeed very popular within the
psychonauts’ niche scenario (81, 82), were self-administered in
a private context, helping to evade the stress, discomfort, and
uncertainties associated with COVID-19.
Limitations
It must be emphasized here that the NPSfinder R© crawling
activity and the further manual analysis was conducted here
only on the surface web. Further studies from our group will
focus on the deep web and darknet, as there may be more
information in the hidden web (83). Moreover, the present
NPSfinder R© findings related mostly to psychonaut and vendor
websites and may not represent the entirety of those NPSs
debated/discussed/mentioned online. Furthermore, one could
argue that of the 18 new NPSs identified here, only 10 were
not in EMCDDA and UNODC databases at the time of the
analysis, and hence only 10 were new. Conversely, as in previous
articles (21–23), we thought that it was useful to provide the
reader with comparison of current with existing data at the
time of the analysis provided by reliable NPS databases such as
the EMCDDA and UNODC. Although eight NPSs were already
identified by these databases, they were discussed online by the
psychonauts at the time of the pandemic, and hence they were
grouped together with the “new” ones. Of course, because of a
range of methodological differences, it may happen that not all
the substances reported by the UNODC and the EMCDDA are
identified by the NPSfinder, and vice versa (22). However, the
evaluation of the NPSfinder performances was beyond the scope
of the current article.
Regarding the qualitative analysis, one could argue that
people posting on the subreddits may not be representative
of the wide community of PWUDs or high-risk groups (e.g.,
homeless, individuals from deprived areas, adolescents/youth,
etc.). Another limitation related here to the sole use of English
as the language chosen for the reddit analysis; this may have
been associated with levels of loss in data collection. Languages
such as Chinese, Japanese, and Arabic were not here included
in the NPSfinder R© searches, but this will occur in future
works. Qualitative methods are at times generally questioned for
reliability and objectivity. Finally, the analysis of data originating
from the subreddits was conducted manually without the use of
any ad hoc software, and this may have introduced levels of bias.
To overcome this issue, two professionals separately analyzed
here the data.
CONCLUSIONS
The analysis of the web presented here has a potential to identify a
range of new and previously unidentified/unreported NPSs, with
the chance of providing information on current drug trends. The
ability of monitoring the net had been proven useful in detecting
possible changes in the online drug markets that can reflect the
real-world situation during such unprecedented times.
The 18 new NPSs identified in this study, and the related
threads analyzed here, showed an appetite for synthetic drugs
during a period of negative economic trend imposed by the
COVID-19 pandemic. Results from the qualitative analysis on
reddit confirmed how opioids represented the most discussed
class of NPSs and the one that should keep getting more attention
from international health and regulatory bodies. We noticed
that while some of these opioids made their first appearance
in redditors’ discussions before COVID-19, related posts and
experiences increased during the first semester of 2020. One
could argue that present findings may be consistent with the
observation that, in times of stress and crisis, PWUDs prefer
drugs that can be used/experienced in solitude to escape the
anxiety, boredom, uncertainty, and discomfort generated by
the COVID-19 pandemic (84). Uncertainty and fear caused by
this unprecedented crisis could push vulnerable people toward
dangerous/risky behavior and increased drug consumption.
Hence, entry into the drug markets of new and perhaps very
potent NPSs is a clear reason of concern.
It is of interest that some of the emerging NPS molecules
here described received the attention of redditors even a few
months before the start of the pandemic; hence, further studies
should combine the use of both web crawlers and social
listening data to optimally identify drug scenarios’ modifications.
These studies, based on a thorough qualitative analysis of both
psychonauts’ fora and social media, should better assess not only
the molecules mentioned by NPS enthusiasts, but also the users’
understanding of the pharmacological characteristics of these
same molecules.
Finally, the current findings indeed support and highlight the
potential and added value of automated web crawlers such as
the NPSfinder R© in scanning the web and retrieve data in an
easy and time-effective way. At present, when a second wave
of COVID-19 is generating further lockdown measures, it will
remain to be seen if online drug sales and/or increased popularity
of some NPSs will persist and influence future drug consumption
patterns (63).
Frontiers in Psychiatry | www.frontiersin.org 9 February 2021 | Volume 11 | Article 632405
Catalani et al. COVID-19 and NPS
DATA AVAILABILITY STATEMENT
The original contributions presented in the study are included
in the article/Supplementary Material, further inquiries can be
directed to the corresponding author.
AUTHOR CONTRIBUTIONS
VC and FS conceived the idea of the manuscript and coordinated
the whole project. VC and DA carried out the process of both
data collection and systematization. VC performed the literature
searching, the analysis of data, and drafted the manuscript. JC
provided data from the EMCDDA and UNODC databases for
the purposes of this research. AV supervised the word done
with NPSfinder R©. FS, AG, and JC contributed to the literature
overview and the drafting of the paper. All authors contributed
to the articles and approved the submitted version.
ACKNOWLEDGMENTS
The authors are grateful to Damicom srl, a small enterprise from
Rome (Italy), whose professionals have developed, under the
supervision of AV and FS, the NPSfinder R© web crawler and so
generously have allowed here the testing of its potential.
SUPPLEMENTARY MATERIAL




1. IMF. World Economic Outlook, April 2020: The Great Lockdown. (2020).
Available online at: https://www.imf.org/en/Publications/WEO/Issues/2020/
04/14/weo-april-2020 (accessed September 8, 2020).
2. WTO. COVID-19 and World Trade. (2020). Available online at: https://www.
wto.org/english/tratop_e/covid19_e/covid19_e.htm (accessed September 7,
2020).
3. WTO. Trade Set to Plunge as COVID-19 Pandemic Upends Global Economy.
(2020). Available online at: https://www.wto.org/english/news_e/pres20_e/
pr855_e.htm (accessed September 7, 2020).
4. UNODC. Executive Summary Effects of covid-19 on Drug Markets World Drug
Report 2020. (2020). Available online at: https://wdr.unodc.org/wdr2020/en/
exsum.html (accessed September 7, 2020).
5. Dubey MJ, Ghosh R, Chatterjee S, Biswas P, Chatterjee S, Dubey S. COVID-
19 and addiction. Diabetes Metab Syndr Clin Res Rev. (2020) 14:817–
23. doi: 10.1016/j.dsx.2020.06.008
6. Chiappini S, Guirguis A, John A, Corkery JM, Schifano F. COVID-19: the
hidden impact on mental health and drug addiction. Front Psychiatry. (2020)
11:767. doi: 10.3389/fpsyt.2020.00767
7. Lima CKT, Carvalho PM, de Medeiros Carvalho M, Lima I de
AAS, Nunes JVA de O, Saraiva JS, et al. The emotional impact of
Coronavirus 2019-nCoV (new Coronavirus disease). Psychiatry Res. (2020)
287:112915. doi: 10.1016/j.psychres.2020.112915
8. Petterson S, Westfall J, Miller B. Projected Deaths of Despair From COVID-19.
(2020). Available online at: https://wellbeingtrust.org
9. Guirguis A. There is a vulnerable group we must not leave behind
in our response to COVID-19: people who are dependent on
illicit drugs. Pharm J. (2020) 304:314–6. doi: 10.1211/PJ.2020.202
07926
10. Varì MR, Berretta P, Palmi I, Graziano S. Drug market and drug addiction
treatment during the COVID-19 pandemic. Minerva Medicolegale. (2020)
140:48–51. doi: 10.23736/S0026-4849.20.01794-0
11. Dubey S, Biswas P, Ghosh R, Chatterjee S, Dubey MJ, Chatterjee S, et al.
Psychosocial impact of COVID-19.Diabetes Metab Syndr Clin Res Rev. (2020)
14:779–88. doi: 10.1016/j.dsx.2020.05.035
12. UNODC.Drug SupplyWorld Drug Report. (2020). Available online at: https://
wdr.unodc.org/wdr2020/en/drug-supply.html (accessed September 11, 2020).
13. UNODC. COVID-19 and the Drug Supply Chain: From Production and
Trafficking to Use. (2020). Available online at: www.unodc.org.
14. UNODC. Current NPS Threats. (2020). Available online at: https://www.
unodc.org/unodc/en/scientists/current-nps-threats.html (accessed April 10,
2020).
15. Di Trana A, Carlier J, Berretta P, Zaami S, Ricci G. Consequences
of COVID-19 lockdown on the misuse and marketing of addictive
substances and new psychoactive substances. Front Psychiatry. (2020)
11:584462. doi: 10.3389/fpsyt.2020.584462
16. Bonello D. Coronavirus Is Leading to Shortages of Fentanyl and Meth.
(2020). Available online at: https://www.vice.com/en_us/article/wxek4m/
coronavirus-is-leading-to-shortages-of-fentanyl-and-meth (accessed
September 11, 2020).
17. Hsieh HF, Shannon SE. Three approaches to qualitative content analysis.Qual
Health Res. (2005) 15:1277–88. doi: 10.1177/1049732305276687
18. Guirguis A, Moosa I, Gittins R, Schifano F. What about
drug checking? Systematic review and netnographic analysis
of social media. Curr Neuropharmacol. (2020) 18:906–
17. doi: 10.2174/1570159X18666200413142632
19. EMCDDA. European Database on New Drugs. (2020). Available online at:
https://ednd2.emcdda.europa.eu (accessed September 4, 2020).
20. UNODC. Early Warning Advisory (EWA) on New Psychoactive Substances
(NPS). (2020). Available online at: https://www.unodc.org/LSS/Home/NPS
(accessed September 4, 2020).
21. Arillotta D, Schifano F, Napoletano F, Zangani C, Gilgar L, Guirguis A,
et al. Novel opioids: systematic web crawling within the e-psychonauts’
scenario. Front Neurosci. (2020) 14:149. doi: 10.3389/fnins.2020.
00149
22. Schifano F, Napoletano F, Arillotta D, Zangani C, Gilgar L, Guirguis A, et al.
The clinical challenges of synthetic cathinones. Br J Clin Pharmacol. (2020)
86:410–9. doi: 10.1111/bcp.14132
23. Zangani C, Schifano F, Napoletano F, Arillotta D, Gilgar L, Guirguis
A, et al. The e-psychonauts’ ‘Spiced’ World; Assessment of the
SCRAs’ information available online. Curr Neuropharmacol. (2020)
18:966–1051. doi: 10.2174/1570159X18666200302125146
24. BBC. China Coronavirus: Lockdown Measures Rise Across Hubei Province.
(2020). Available online at: https://www.bbc.com/news/world-asia-china-
51217455 (accessed September 21, 2020).
25. Abdulrahim D, Bowden-Jones O. Guidance on the Clinical Management of
Acute and Chronic Harms of Club Drugs and Novel Psychoactive Substances.
(2015). Available online at: http://www.drugsandalcohol.ie/24292/
26. Schifano F, Orsolini L, Duccio Papanti G, Corkery JM. Novel psychoactive
substances of interest for psychiatry. World Psychiatry. (2015) 14:15–
26. doi: 10.1002/wps.20174
27. Schifano F, Napoletano F, Chiappini S, Guirguis A, Corkery JM,
Bonaccorso S, et al. New/emerging psychoactive substances and
associated psychopathological consequences. Psychol Med. (2019).
doi: 10.1017/S0033291719001727. [Epub ahead of print].
28. Heller SR, McNaught A, Pletnev I, Stein S, Tchekhovskoi D. InChI,
the IUPAC international chemical identifier. J Cheminform. (2015) 7:23.
doi: 10.1186/s13321-015-0068-4
29. Heller S, McNaught A, Stein S, Tchekhovskoi D, Pletnev I. InChI - the
worldwide chemical structure identifier standard. J Cheminform. (2013)
5:7. doi: 10.1186/1758-2946-5-7
30. Reddit. reddit: The Front Page of the Internet. (2020). Available online at:
https://www.reddit.com/ (accessed October 8, 2020).
Frontiers in Psychiatry | www.frontiersin.org 10 February 2021 | Volume 11 | Article 632405
Catalani et al. COVID-19 and NPS
31. Statista. Reddit Users: Unique Monthly Visits 2019. (2019). Available online
at: https://www.statista.com/statistics/443332/reddit-monthly-visitors/
(accessed October 29, 2020).
32. Booth C. Reddit Surpasses Facebook to Become the 3rd Most Visited Site in the
US. (2018). Available online at: https://thenextweb.com/facebook/2018/05/
30/reddit-surpasses-facebook-to-become-the-3rd-most-visited-site-in-the-
us/ (accessed October 29, 2020).
33. FOUNDATION. Reddit Statistics for 2020: Eye-Opening Usage & Traffic Data.
(2020). Available online at: https://foundationinc.co/lab/reddit-statistics/
(accessed October 29, 2020).
34. Du C, Lee W, Amin KA, Lucioni A, Kobashi KC, Lee UJ. “Beyond the Bump”
– insight into the postpartum women’s experience of pelvic organ prolapse
as expressed on Reddit. Urology. (2020). doi: 10.1016/j.urology.2020.08.026.
[Epub ahead of print].
35. Du C, Lee W, Moskowitz D, Lucioni A, Kobashi KC, Lee UJ. I leaked, then
I Reddit: experiences and insight shared on urinary incontinence by Reddit
users. Int Urogynecol J. (2020) 31:243–8. doi: 10.1007/s00192-019-04165-8
36. Liu H, Li Q, Zhan Y, Zhang Z, Zeng DD, Leischow SJ. Characterizing
social media messages related to underage JUUL E-cigarette buying and
selling: cross-sectional analysis of reddit subreddits. J Med Internet Res. (2020)
22:e16962. doi: 10.2196/16962
37. Picone M, Inoue S, DeFelice C, Naujokas MF, Sinrod J, Cruz
VA, et al. Social listening as a rapid approach to collecting and
analyzing COVID-19 symptoms and disease natural histories reported
by large numbers of individuals. Popul Health Manag. (2020)
23:350–60. doi: 10.1089/pop.2020.0189
38. Reddit. Research Chemicals Discussion - Strictly No Sourcing. (2020). Available
online at: https://www.reddit.com/r/researchchemicals/ (accessed November
2, 2020).
39. Reddit. r/Dissociatives. (2020). Available online at: https://www.reddit.com/r/
dissociatives/ (accessed November 16, 2020).
40. Reddit. r/Opioid_RCs. (2020). Available online at: https://www.reddit.com/r/
Opioid_RCs/ (accessed November 16, 2020).
41. Reddit. r/stims. (2020). Available online at: https://www.reddit.com/r/Stims/
(accessed November 16, 2020).
42. Reddit. r/Noids. (2020). Available online at: https://www.reddit.com/r/noids/
(accessed November 16, 2020).
43. FIMEA (2014). notification_impact_assessm_2014_654_FIN_EN. Available
online at: https://ec.europa.eu
44. Isomer design. MDPEP | PiHKAL. (2019). Available online at: http://
isomerdesign.com/PiHKAL/explore.php?domain=pk&id=6996&name=
MDPEP (accessed September 21, 2020).
45. Baumann MH, Majumdar S, Le Rouzic V, Hunkele A, Uprety R, Huang XP, et
al. Pharmacological characterization of novel synthetic opioids (NSO) found
in the recreational drug marketplace. Neuropharmacology. (2018) 134:101–7.
doi: 10.1016/j.neuropharm.2017.08.016
46. Kolanos R, Sakloth F, Jain AD, Partilla JS, Baumann MH,
Glennon RA. Structural modification of the designer stimulant
α-Pyrrolidinovalerophenone (α-PVP) influences potency at
dopamine transporters. ACS Chem Neurosci. (2015) 6:1726-31.
doi: 10.1021/acschemneuro.5b00160
47. Krotulski AJ, Shuda SA, Fogarty MF, Decker SE, Logan BK. NMS Lab 4F-
MDMB-BICA. (2020). Available online at: https://www.caymanchem.com/
product/31075/4-fluoro-mdmb-butica
48. Cayman Chemical. 5-fluoro NPB-22. (2020). Available online at: https://www.
caymanchem.com/product/15536/5-fluoro-npb-22 (accessed September 21,
2020).
49. EMCDDA. EU Early Warning System Situation Report. Luxembourg:
EMCDDA (2020).
50. Hunger A, Kebrle J, Rossi A, Hoffmann K. Benzimidazol-
derivate und verwandte Heterocyclen. II. Synthese von 1-
Aminoalkyl-2-benzyl-benzimidazolen. Helv Chim Acta. (1960)
43:800–9. doi: 10.1002/hlca.19600430323
51. UNODC. China: Announcement to Place All Fentanyl-Related Substances
Under National Control. (2019). Available online at: https://www.unodc.
org/LSS/announcement/Details/f2adea68-fbed-4292-a4cc-63771c943318
(accessed September 21, 2020).
52. Hunger A, Kebrle J, Rossi A, Hoffmann K. Synthese basisch substituierter,
analgetisch wirksamer Benzimidazol-Derivate. Experientia. (1957) 13:400–1.
doi: 10.1007/BF02161116
53. Nakamura H, Natsuka K, Nishimura H, Shimizu M, Shimokawa N, Uno H.
1-Substituted-4-(1,2-diphenylethyl)piperazine Derivatives and Compositions
Containing the Same. (1978). Available online at: https://worldwide.espacenet.
com/patent/search/family/027549542/publication/US4080453A?q=pn
%3DUS4080453 (accessed September 29, 2020).
54. Natsuka K, Nakamura H, Nishikawa Y, Negoro T, Uno H, Nishimura
H. Synthesis and structure–activity relationships of 1-substituted 4-(l,2-
diphenylethyl)piperazine derivatives having narcotic agonist and antagonist
activity. J Med Chem. (1987) 30:1779–87. doi: 10.1021/jm00393a017
55. Hajda JP, Jähnchen E, Øie S, Trenk D. Sequential first-pass metabolism of
nortilidine: the active metabolite of the synthetic opioid drug tilidine. J Clin
Pharmacol. (2002) 42:1257–61. doi: 10.1177/009127002762491352
56. EUsynth.org. Research Chemicals. (2020). Available online at: https://eusynth.
org/research-chemicals.html (accessed September 21, 2020).
57. Exdechem.com (2020). Available online at: http://exdechem.com/new/mfpvp.
html (accessed October 16, 2020).
58. LabsEU.com. New Chemical Research Online. (2020). Available online at:
http://labseu.com/category/new (accessed September 21, 2020).
59. rcvendors.com. Research Chemicals Trusted Vendors - Research Chemicals
Forums. (2020). Available online at: https://rcvendors.com/index.php?topic=
353.0 (accessed October 16, 2020).
60. Corazza O, Assi S, Simonato P, Corkery J, Bersani FS, Demetrovics Z, et al.
Promoting innovation and excellence to face the rapid diffusion of novel
psychoactive substances in the EU: the outcomes of the ReDNet project.Hum
Psychopharmacol. (2013) 28:317–23. doi: 10.1002/hup.2299
61. Orsolini L, Corkery JM, Chiappini S, Guirguis A, Vento A,
De Berardis D, et al. “New/designer benzodiazepines”: an
analysis of the literature and psychonauts’ trip reports. Curr
Neuropharmacol. (2020) 18:809–37. doi: 10.2174/1570159X18666200110
121333
62. UNODC. World Drug Report 2019. (2019). Available online at: https://wdr.
unodc.org/wdr2019/index.html (accessed March 26, 2020).
63. EMCDDA. European Drug Report 2020: Trends and Developments.
Luxembourg: EMCDDA (2020).
64. UNODC. Current NPS Threats Volume II. (2020). Available online at: https://
www.unodc.org/documents/scientific/Current_NPS_Threats_Volume_II_
Web.pdf (accessed May 6, 2020).
65. Zaami S, Marinelli E, Varì MR. New trends of substance abuse during
COVID-19 pandemic: an international perspective. Front Psychiatry. (2020)
11:700. doi: 10.3389/fpsyt.2020.00700
66. EMCDDA. EMCDDA Update on the Implications of COVID-19 for People
Who Use Drugs and Drug Service Providers. (2020). Available online at:
https://www.emcdda.europa.eu/publications/topic-overviews/catalogue/
covid-19-and-people-who-use-drugs (accessed September 22, 2020).
67. EMCDDA. Trendspotter Briefing I Impact of COVID-19 on Drug Services and
Help-Seeking in Europe. Luxembourg: EMCDDA (2020).
68. WHO. Pulse Survey on Continuity of Essential Health Services During the
COVID-19 Pandemic: Interim Report, 27 August 2020. (2020). Available
online at: https://www.who.int/publications/i/item/WHO-2019-nCoV-EHS_
continuity-survey-2020.1 (accessed October 29, 2020).
69. GDS. Global Drug Survey Special Edition on COVID-19. (2020). Available
online at: https://www.globaldrugsurvey.com/wp-content/themes/
globaldrugsurvey/assets/GDS_COVID-19-GLOBAL_Interim_Report-
2020.pdf (accessed October 28, 2020).
70. McCann Pineo M, Schwartz RM. Commentary on the coronavirus
pandemic: anticipating a fourth wave in the opioid epidemic. Psychol
Trauma Theory Res Pract Policy. (2020) 12:S108–10. doi: 10.1037/tra00
00622
71. EMCDDA-Europol. EU Drug Markets: Impact of COVID-19. Luxembourg:
EMCDDA-Europol (2020).
72. WHO. Opioid Overdose. (2020). Available online at: https://www.who.int/
news-room/fact-sheets/detail/opioid-overdose (accessed October 16, 2020).
73. UNODC. Outcome Document of the 2016 United Nation General Assembly
Special Session on the World Drug Problem. New York, NY: UNODC (2016).
Frontiers in Psychiatry | www.frontiersin.org 11 February 2021 | Volume 11 | Article 632405
Catalani et al. COVID-19 and NPS
74. UNODC. Understanding the Global Opioid Crisis. (2019). Available
online at: https://www.unodc.org/unodc/en/scientists/global-smart-update-
2019-vol-21.html. (accessed October 29, 2020).
75. UNODC. The Growing Complexity of the Opioid Crisis Smart Update, Vol.
2. (2020). 4en. Available online at: www.unodc.org/tox (accessed October 29,
2020).
76. Armenian P, Vo KT, Barr-Walker J, Lynch KL. Fentanyl, fentanyl analogs and
novel synthetic opioids: a comprehensive review. Neuropharmacology. (2018)
134:121–32. doi: 10.1016/j.neuropharm.2017.10.016
77. Wilde M, Pichini S, Pacifici R, Tagliabracci A, Busardò FP, Auwärter V, et al.
Metabolic pathways and potencies of new fentanyl analogs. Front Pharmacol.
(2019) 10:238. doi: 10.3389/fphar.2019.00238
78. Cannaert A, Hulpia F, Risseeuw M, Van Uytfanghe K, Deconinck E,
Van Calenbergh S, et al. Report on a new opioid NPS: chemical and
in vitro functional characterization of a structural isomer of the MT-
45 derivative diphenpipenol. J Anal Toxicol. (2020). doi: 10.1093/jat/bk
aa066. [Epub ahead of print].
79. Cheng S, Yeo J, Brown E, Regan A. Bath salts and synthetic cannabinoids: a
review. Am Acad Emerg Med. (2012) 19–22. Available online at: https://www.
medscape.com/viewarticle/765892_2
80. Krotulski AJ, Cannaert A, Stove C, Logan BK. The next generation of SCRAs:
detection, activity, potential toxicity of pent-4en but-3en analogues including
MDMB-4en-PINACA. Drug Test Anal. (2020). doi: 10.1002/dta.2935. [Epub
ahead of print].
81. Orsolini L, Papanti GD, Francesconi G, Schifano F. Mind
navigators of chemicals’ experimenters? A web-based description
of E-psychonauts. Cyberpsychol Behav Soc Netw. (2015) 18:296–300.
doi: 10.1089/cyber.2014.0486
82. Orsolini L, Papanti GD, Francesconi G, Schifano F. Navigating in the
virtual mind of the web’: the E-psychonauts’ profiling. Eur Psychiatry. (2015)
30:1045. doi: 10.1016/S0924-9338(15)30822-1
83. Orsolini L, Papanti D, Corkery J, Schifano F. An insight into the deep web;
why it matters for addiction psychiatry? Hum Psychopharmacol. (2017) 32.
doi: 10.1002/hup.2573
84. Chiappini S, Schifano F. What about “pharming”? Issues regarding the
misuse of prescription and over-the-counter drugs. Brain Sci. (2020)
10:736. doi: 10.3390/brainsci10100736
Conflict of Interest: The authors declare that the NPSfinder R© web-crawler was
provided by Damicon srl.
The remaining authors declare that the research was conducted in the absence of
any commercial or financial relationships that could be construed as a potential
conflict of interest.
Copyright © 2021 Catalani, Arillotta, Corkery, Guirguis, Vento and Schifano. This
is an open-access article distributed under the terms of the Creative Commons
Attribution License (CC BY). The use, distribution or reproduction in other forums
is permitted, provided the original author(s) and the copyright owner(s) are credited
and that the original publication in this journal is cited, in accordance with accepted
academic practice. No use, distribution or reproduction is permitted which does not
comply with these terms.
Frontiers in Psychiatry | www.frontiersin.org 12 February 2021 | Volume 11 | Article 632405
